ICU MEDICAL INC

ICU Medical, Inc. (NASDAQ: ICUI) develops, manufactures, and sells innovative medical products used in infusion therapy, vascular access, and vital care applications. Founded in 1984 and headquartered in San Clemente, California, the company serves acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities across more than 100 countries worldwide. More information is available at www.icumedical.com.

The company operates through a diversified portfolio organized into two primary business units: Consumables and Infusion Systems. The Consumables segment includes Infusion Therapy products such as needlefree connectors and disinfection caps under brands like Clave and ClearGuard, Oncology products including closed system transfer devices for hazardous drug preparation, Vascular Access products including the Jelco peripheral IV catheter line, and Tracheostomy products marketed under the Portex brand. The Infusion Systems segment offers large volume pumps including the Plum 360 and Plum precision pump lines, ambulatory infusion pumps under the CADD brand, syringe infusion pumps marketed as Medfusion, and IV medication safety software platforms including LifeShield and ICU Medical MedNet. The Vital Care business unit encompasses hemodynamic monitoring systems, general anesthesia and respiratory products, temperature management solutions, regional anesthesia trays, and IV solutions distributed through a joint venture with Otsuka Pharmaceutical Factory America.

ICU Medical has grown through strategic acquisitions, including Pfizer's Hospira Infusion Systems business in 2017, Pursuit Vascular in 2019, and Smiths Medical in 2022, which significantly expanded its global market reach and product portfolio. The company maintains manufacturing facilities in the United States, Costa Rica, Mexico, and the Czech Republic, supported by regional device service centers and distribution networks across North America, Europe, Asia-Pacific, and other markets. The company distributes products through its own direct sales force and independent distributors, with significant sales denominated in U.S. dollars alongside international currency exposure. ICU Medical's products are subject to extensive FDA regulation and international regulatory requirements, reflecting the highly controlled nature of medical device manufacturing and commercialization.